Julija Čiauškaitė 1,*, Ieva Puleikytė1, Simonas Jesmanas 2, Giedrė
Jurkevičienė 1, Antanas Vaitkus 1and Daiva Rastenytė 1
1 Department of Neurology, Medical Academy, Lithuanian
University of Health Sciences;
2 Department of Radiology, Medical Academy, Lithuanian
University of Health Sciences;
* Correspondence:
juliciau0522@kmu.lt.
Key Clinical Message: Neuroleptic malignant syndrome associated
with quetiapine in a patient with Creutzfeldt-Jakob disease.
Abstract: Creutzfeldt – Jakob disease (CJD) is a rare
neurodegenerative disease with complex clinical manifestations.
Neuroleptic malignant syndrome (NMS) is a complication of antipsychotic
medications which are used to treat neuropsychiatric symptoms of CJD. We
present a case of a 51-year-old woman with CJD who developed NMS after
being prescribed quetiapine.
Keywords: Creutzfeldt-Jakob disease; neuroleptic malignant
syndrome; magnetic resonance imaging; electroencephalography.